BioSpace News Archive

BioCareSD today announced the continued expansion of specialty therapies offered for their customer base by bringing on board BIMZELX, a prescription medication used to treat adults with moderate to severe plaque psoriasis.

Trinity Biotech plc announced that on November 21, 2023 the Company received notice from the Nasdaq Stock Market LLC that the Company is not in compliance with the minimum market value of publicly held shares requirement set forth in the Nasdaq Listing Rules.

Adverum Biotechnologies, Inc. announced that Linda Rubinstein, chief financial officer, and Star Seyedkazemi, chief development officer of Adverum Biotechnologies, will participate in a fireside chat at the Evercore ISI 6th Annual HealthCONx Conference on Wednesday, November 29, 2023 at 3:50 p.m. ET in Miami, Florida.

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Evercore ISI HealthCONx Conference this week in Miami, FL.

IntelGenx Technologies Corp. is pleased to announce that, at its meeting held earlier , the shareholders voted to approve all proposals related to financing transactions involving atai Life Sciences AG previously disclosed by the Company on August 31, 2023.

Alvotech (NASDAQ: ALVO, or the “Company”) today reported unaudited financial results for the first nine months of 2023 and provided a summary of recent corporate highlights.

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) will present at the Sidoti Small-Cap Virtual Investor Conference at 8:30 a.m. ET on Wednesday, December 6, 2023.

MedMira Inc., reported on its financial results for the financial year ended July 31, 2023.

AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease.

Merck, known as MSD outside of the United States and Canada, announced that the Board of Directors has declared a quarterly dividend of $0.77 per share of the company’s common stock for the first quarter of 2024.